South Western Sydney Clinical School

Sindone A; Erlich J; Lee C; Newman H; Suranyi M; Roger SD, 2016, 'Cardiovascular risk reduction in hypertension: Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?', Internal Medicine Journal, vol. 46, pp. 364 - 372, http://dx.doi.org/10.1111/imj.12975

Nandakoban H; Aravindan A; Spicer T; Narayanan G; Gonzalez N; Suranyi M; Wong JKW, 2016, 'The impact of tunnelled vascular catheters on time to arteriovenous fistula creation', Journal of Vascular Access, vol. 17, pp. 63 - 66, http://dx.doi.org/10.5301/jva.5000454

Moe SM; Chertow GM; Parfrey PS; Kubo Y; Block GA; Correa-Rotter R; Drüeke TB; Herzog CA; London GM; Mahaffey KW, 2015, 'Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: The evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial', Circulation, vol. 132, pp. 27 - 39, http://dx.doi.org/10.1161/CIRCULATIONAHA.114.013876

Parfrey PS; Drüeke TB; Block GA; Correa-Rotter R; Floege J; Herzog CA; London GM; Mahaffey KW; Moe SM; Wheeler DC, 2015, 'The effects of cinacalcet in older and younger patients on hemodialysis: The evaluation of cinacalcet HCL therapy to lower cardiovascular events (EVOLVE) trial', Clinical Journal of the American Society of Nephrology, vol. 10, pp. 791 - 799, http://dx.doi.org/10.2215/CJN.07730814

Cho Y; Johnson DW; Vesey DA; Hawley CM; Clarke M; Topley N; Rangan G; Liew L; Kulkarni H; Steinwandel U, 2015, 'Utility of urinary biomarkers in predicting loss of residual renal function: The Balanz trial', Peritoneal Dialysis International, vol. 35, pp. 159 - 171, http://dx.doi.org/10.3747/pdi.2013.00170

Johnson DW; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E, 2015, 'A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: The handling erythropoietin resistance with oxpentifylline', American Journal of Kidney Diseases, vol. 65, pp. 49 - 57, http://dx.doi.org/10.1053/j.ajkd.2014.06.020

Chow J; Jobburn K; Suranyi M; Chapman M, 2014, 'Excellence in innovative implementation of clinical guidelines-the empowerment of the consumer with chronic kidney disease', RENAL SOCIETY OF AUSTRALASIA JOURNAL, vol. 10, pp. 91 - 92, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437149200009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chan R; Brooks R; Erlich J; Gallagher M; Snelling P; Chow J; Suranyi M, 2014, 'How do clinical and psychological variables relate to quality of life in end-stage renal disease? Validating a proximal-distal model.', Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, vol. 23, pp. 677 - 686, http://dx.doi.org/10.1007/s11136-013-0499-1

Aravindan A; Suranyi M; Saunders J; Yong J; Cleland B, 2013, 'A deadly thorn prick.', Clin Kidney J, vol. 6, pp. 334 - 337, http://dx.doi.org/10.1093/ckj/sfs058

Sindone A; Erlich J; Perkovic V; Suranyi M; Newman H; Lee C; Barin E; Roger SD, 2013, 'ACEIs for cardiovascular risk reduction--have we taken our eye off the ball?', Aust Fam Physician, vol. 42, pp. 634 - 638, https://www.ncbi.nlm.nih.gov/pubmed/24024224

Sindone A; Erlich J; Perkovic V; Suranyi M; Newman H; Lee C; Barin E; Roger SD, 2013, 'ACEIs for cardiovascular risk reduction: Have we taken our eye off the ball?', Australian Family Physician, vol. 42, pp. 634 - 638

Cheikh Hassan H; Makris A; Suranyi MG; Wong JKW, 2013, 'Prescription medications and their influence on acute kidney injury presentation and outcomes', Internal Medicine Journal, vol. 43, pp. 706 - 712, http://dx.doi.org/10.1111/imj.12137

Mai J; Yong J; Dixson H; Makris A; Aravindan A; Suranyi MG; Wong J, 2013, 'Is bigger better? A retrospective analysis of native renal biopsies with 16 Gauge versus 18 Gauge automatic needles', Nephrology, vol. 18, pp. 525 - 530, http://dx.doi.org/10.1111/nep.12093

Ting RD; Keech AC; Drury PL; Donoghoe MW; Hedley J; Jenkins AJ; Davis TME; Lehto S; Celermajer D; Simes RJ, 2012, 'Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes and renal impairment: The FIELD study', Diabetes Care, vol. 35, pp. 218 - 225, http://dx.doi.org/10.2337/dc11-1109

Chow JSF; Rayment G; Britos V; Cleland B; Suranyi M, 2012, 'Change process during synchronised conversion to a once-monthly erythropoiesis-stimulating agent (ESA) administration at a single satellite haemodialysis unit.', J Ren Care, vol. 38, pp. 191 - 201, http://dx.doi.org/10.1111/j.1755-6686.2012.00318.x

Johnson DW; Brown FG; Clarke M; Boudville N; Elias TJ; Foo MWY; Jones B; Kulkarni H; Langham R; Ranganathan D, 2012, 'Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes.', J Am Soc Nephrol, vol. 23, pp. 1097 - 1107, http://dx.doi.org/10.1681/ASN.2011121201

Chow J; Rayment G; Britos V; Cleland B; Suranyi M, 2012, 'Getting 'in sync' with anemia management.', Nephrol Nurs J, vol. 39, pp. 145 - 146, https://www.ncbi.nlm.nih.gov/pubmed/22690449

Galle JC; Claes K; Kiss I; Winearls CG; Herlitz H; Guerin A; Di Giulio S; Suranyi MG; Bridges I; Addison J, 2012, 'An observational cohort study of extended dosing (once every 2 weeks or once monthly) regimens with darbepoetin alfa in patients with chronic kidney disease not on dialysis: The EXTEND study', Nephrology Dialysis Transplantation, vol. 27, pp. 2303 - 2311, http://dx.doi.org/10.1093/ndt/gfr677

Johnson DW; Brown FG; Clarke M; Boudville N; Elias TJ; Foo MWY; Jones B; Kulkarni H; Langham R; Ranganathan D, 2012, 'The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: The balANZ trial', Peritoneal Dialysis International, vol. 32, pp. 497 - 506, http://dx.doi.org/10.3747/pdi.2012.00052

Johnson DW; Brown FG; Clarke M; Boudville N; Elias TJ; Foo MWY; Jones B; Kulkarni H; Langham R; Ranganathan D, 2012, 'The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: The balANZ trial', Nephrology Dialysis Transplantation, vol. 27, pp. 4445 - 4453, http://dx.doi.org/10.1093/ndt/gfs314

Chan R; Brooks R; Steel Z; Heung T; Erlich J; Chow J; Suranyi M, 2012, 'The psychosocial correlates of quality of life in the dialysis population: A systematic review and meta-regression analysis', Quality of Life Research, vol. 21, pp. 563 - 580, http://dx.doi.org/10.1007/s11136-011-9973-9

Nandakoban H; Aravindan AN; Spicer ST; Gonzalez N; Suranyi M; Wong JKW, 2011, 'THE IMPACT OF TUNNELLED VASCULAR CATHETERS (TVC) ON TIME TO ARTERIOVENOUS FISTULA CREATION', NEPHROLOGY, vol. 16, pp. 28 - 29, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294977600020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lopez-Vargas PA; Craig JC; Gallagher MP; Walker RG; Snelling PL; Pedagogos E; Gray NA; Divi MD; Gillies AH; Suranyi MG, 2011, 'Barriers to timely arteriovenous fistula creation: A study of providers and patients', American Journal of Kidney Diseases, vol. 57, pp. 873 - 882, http://dx.doi.org/10.1053/j.ajkd.2010.12.020

Chan R; Brooks R; Erlich J; Gallagher M; Snelling P; Chow J; Suranyi M, 2011, 'Studying psychosocial adaptation to end-stage renal disease: The proximal-distal model of health-related outcomes as a base model', Journal of Psychosomatic Research, vol. 70, pp. 455 - 464, http://dx.doi.org/10.1016/j.jpsychores.2010.11.005

Chan R; Steel Z; Brooks R; Heung T; Erlich J; Chow J; Suranyi M, 2011, 'Psychosocial risk and protective factors for depression in the dialysis population: A systematic review and meta-regression analysis', Journal of Psychosomatic Research, vol. 71, pp. 300 - 310, http://dx.doi.org/10.1016/j.jpsychores.2011.05.002

Suranyi M; Chow JSF, 2010, 'Review: anticoagulation for haemodialysis.', Nephrology (Carlton), vol. 15, pp. 386 - 392, http://dx.doi.org/10.1111/j.1440-1797.2010.01298.x

Aravindan A; Yong J; Killingsworth M; Suranyi M; Wong J, 2010, 'Minimal change disease with interferon-beta therapy for relapsing remitting multiple sclerosis', NDT Plus, vol. 3, pp. 132 - 134, http://dx.doi.org/10.1093/ndtplus/sfp162

Aravindan A; Yong J; Killingsworth M; Strasser S; Suranyi M, 2010, 'An unusual renal manifestation of chronic HBV infection', NDT Plus, vol. 3, pp. 360 - 362, http://dx.doi.org/10.1093/ndtplus/sfq086

Chan R; Brooks R; Gallagher M; Erlich J; Snelling P; Chow J; Suranyi M, 2010, 'Measuring kidney disease-related loss in samples of predialysis and dialysis patients: Validating the kidney disease loss scale', Clinical Journal of the American Society of Nephrology, vol. 5, pp. 1249 - 1254, http://dx.doi.org/10.2215/CJN.08361109

Aravindan A; Yong J; Killingsworth MC; Strasser S; Suranyi MG, 2010, 'Case Report: An unusual renal manifestation of chronic HBV infection', CKJ – Clinical Kidney Journal, vol. 3, pp. 360 - 362

Chan R; Brooks; Gallagher M; Erlich JH; Snelling P; Chow J; Suranyi MG, 2010, 'Measuring Kidney-Disease-Related Loss in the samples of pre-dialysis and dialysis patients: Validating the Kidney Disease Loss Scale', Clinical Journal of the American Society of Nephrology, vol. 5, pp. 1249 - 1254

Aravindan A; Yong JM; Killingsworth MC; Suranyi MG; Wong J, 2010, 'Minimal change disease with interferon-beta therapy for relapsing remitting multiple sclerosis', CKJ – Clinical Kidney Journal, vol. 3, pp. 134

Chow J; Suranyi MG, 2009, 'A Survey of Australian patient preferences regarding subcutaneous erythropoiesis-stimulating agents', RENAL SOCIETY OF AUSTRALASIA JOURNAL, vol. 5, pp. 16 - 26, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437074200003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chow J; Rayment G; Wong J; Jefferys A; Suranyi M, 2009, 'Needle-stick injury: a novel intervention to reduce the occupational health and safety risk in the haemodialysis setting.', J Ren Care, vol. 35, pp. 120 - 126, http://dx.doi.org/10.1111/j.1755-6686.2009.00093.x

Suranyi MG; Tolman C, 2009, 'EXTEND: AN OBSERVATIONAL COHORT STUDY OF EXTENDED DOSING WITH ARANESP (R) (DARBEPOETIN ALFA) IN CHRONIC KIDNEY DISEASE PATIENTS NOT ON DIALYSIS - INTERIM ANALYSIS', NEPHROLOGY, vol. 14, pp. A50 - A51, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270272500188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chan R; Brooks; Erlich JH; Chow J; Suranyi MG, 2009, 'The effects of kidney-disease-related loss on long-term dialysis patients' depression and quality of life: positive affect as a mediator', Clinical Journal of the American Society of Nephrology, vol. 4, pp. 160 - 167

Roger SD; Suranyi MG; Walker RG; Disney A; Isbel NM; Kairaitis L; Pollock CA; Brown FG; Chow J; Truman MI, 2008, 'A randomised, cross-over study comparing injection site pain with subcutaneous epoetin beta and subcutaneous darbepoetin alfa in patients with chronic kidney disease', Current Medical Research and Opinion, vol. 24, pp. 2181 - 2187, http://dx.doi.org/10.1185/03007990802240552

Aravindan AN; Saunders J; Wong J; Howlin KJ; Jefferys A; Makris A; Spicer ST; Suranyi MG; Cleland BG, 2007, 'A DEADLY THORN PRICK', NEPHROLOGY, vol. 12, pp. A24 - A24, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Arayindan AN; Saunders J; Depczynski B; Wong J; Cleland BG; Jefferys A; Makris A; Spicer ST; Suranyi MG; Howlin KJ, 2007, 'WHAT IS SO UNUSUAL ABOUT HYPERCALCAEMIA IN MYELOMA?', NEPHROLOGY, vol. 12, pp. A9 - A9, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Aravindan AN; Saunders J; Munshi S; Howlin KJ; Cleland BG; Jefferys A; Makris A; Spicer ST; Suranyi MG; Wong J, 2007, 'VARICELLA ZOSTER IN RENAL TRANSPLANT PATIENTS - A CASE FOR SCREENING AND VACCINATION', NEPHROLOGY, vol. 12, pp. A29 - A29, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Saunders J; Aravindan AN; Gonzalez N; Howlin KJ; Jefferys A; Makris A; Spicer ST; Suranyi MG; Cleland BG; Wong J, 2007, 'DO TUNNELED CUFFED HAEMODIALYSIS CATHETERS JUST FALL OUT?', NEPHROLOGY, vol. 12, pp. A24 - A25, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Saunders J; Aravindan AN; Wong J; Howlin KJ; Cleland BG; Jefferys A; Makris A; Spicer ST; Suranyi MG, 2007, 'A RARE CAUSE OF CAPD PERITONITIS', NEPHROLOGY, vol. 12, pp. A38 - A39, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Saunders J; Aravindan AN; Leung D; Howlin KJ; Jefferys A; Makris A; Spicer ST; Suranyi MG; Wong J; Cleland BG, 2007, 'EMBOLIZE THE FISTULA, SAVE A LIFE', NEPHROLOGY, vol. 12, pp. A38 - A38, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500151&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Saunders J; Aravindan AN; Knagge D; Wong J; Howlin KJ; Cleland BG; Jefferys A; Makris A; Spicer ST; Suranyi MG, 2007, 'THE SAFETY OF IRON POLYMALTOSE IN CHRONIC KIDNEY DISEASE PATIENTS', NEPHROLOGY, vol. 12, pp. A45 - A45, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500174&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Saunders J; Aravindan AN; Gonzalez N; Howlin KJ; Jefferys A; Makris A; Spicer ST; Suranyi MG; Cleland BG; Wong J, 2007, 'IS RIGHT OR LEFT BETTER? TUNNELED INTERNAL JUGULAR HAEMODIALYSIS CATHETERS', NEPHROLOGY, vol. 12, pp. A24 - A24, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Aravindan AN; Saunders J; Wong J; Cleland BG; Makris A; Spicer ST; Suranyi MG; Howlin KJ; Jefferys A, 2007, 'ATYPICAL KNEE PAIN POST RENAL TRANSPLANT', NEPHROLOGY, vol. 12, pp. A29 - A29, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500112&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Aravindan AN; Saunders J; Gonzalez N; Howlin KJ; Cleland BG; Jefferys A; Makris A; Spicer ST; Suranyi MG; Wong J, 2007, 'CATHETERS BELOW THE BELT: HOW DO FEMORAL TUNNELED HAEMODIALYSIS CATHETERS FARE?', NEPHROLOGY, vol. 12, pp. A24 - A24, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652500094&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Aravindan AN; Saunders J; Cleland B; Spicer T; Howlin K; Wong J; Jefferys A; Chow J; Henderson C; Suranyi M, 2007, 'Pyrexia of unknown origin (PUO) in a hemodialysis patient', International Urology and Nephrology, vol. 39, pp. 1277 - 1280, http://dx.doi.org/10.1007/s11255-007-9285-8

Perkovic V; Joshi R; Patel A; Bompoint S; Chalmers J; ADVANCE Collaborative Group, 2006, 'ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes.', Blood Press, vol. 15, pp. 340 - 346, http://dx.doi.org/10.1080/08037050601066074

Aravindan AN; Suranyi MG; Howlin KG; Cleland B; Spicer T; Jefferys A; Wong J, 2006, 'ACUTE NEPHROTIC SYNDROME WITH INTERFERON B', NEPHROLOGY, vol. 11, pp. A11 - A11, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652400042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Aravindan AN; Howlin K; Cleland B; Spicer T; Wong J; Jefferys A; Suranyi MG, 2006, 'SYSTEMIC FUNGAL INFECTION POST RENAL TRANSPLANT; A CASE STUDY', NEPHROLOGY, vol. 11, pp. A40 - A40, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652400163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chow JSF; Rayment G; SanMiguel S; Suranyi MG, 2005, 'Continuous Versus Intermittent Intravenous Iron Administration In Haemodialysis Patients On Erythropoietin: A Randomised Controlled Study', RENAL SOCIETY OF AUSTRALASIA JOURNAL, vol. 1, pp. 14 - 17, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000437065700002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chalmers J, 2005, 'ADVANCE - Action in diabetes and vascular disease: Patient recruitment and characteristics of the study population at baseline', Diabetic Medicine, vol. 22, pp. 882 - 888, http://dx.doi.org/10.1111/j.1464-5491.2005.01596.x

Steele RH; Limaye S; Cleland B; Chow J; Suranyi MG, 2005, 'Hypersensitivity reactions to the polysorbate contained in recombinant erythropoietin and darbepoietin', Nephrology, vol. 10, pp. 317 - 320, http://dx.doi.org/10.1111/j.1440-1797.2005.00389.x

Suranyi MG, 2005, '. Effect of rosuvastatin on outcomes in chronic haemodialysis patients – design and rationale of the AURORA study', Current Controlled Trials In Cardiovascular Medicine, vol. 6, pp. 9 - 9

Suranyi MG, 2005, 'Effects of long term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomized controlled trial', Lancet, vol. 366, pp. 1849 - 1861

Block GA; Martin KJ; De Francisco ALM; Turner SA; Avram MM; Suranyi MG; Hercz G; Cunningham J; Abu-Alfa AK; Messa P, 2004, 'Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis', New England Journal of Medicine, vol. 350, pp. 1516 - 1525, http://dx.doi.org/10.1056/NEJMoa031633

Barré P; Reichel H; Suranyi MG; Barth C, 2004, 'Efficacy of once-weekly epoetin alfa', Clinical Nephrology, vol. 62, pp. 440 - 448

Jefferys A; Chow JSF; Suranyi MG, 2003, 'Acute vascular access catheters for haemodialysis: Complications limiting technique survival', Nephrology, vol. 8, pp. 16 - 20, http://dx.doi.org/10.1046/j.1440-1797.2003.00139.x

Suranyi MG; Lindberg JS; Navarro J; Elias C; Brenner RM; Walker R, 2003, 'Treatment of anemia with darbepoetin alfa administered de novo once every other week in chronic kidney disease', American Journal of Nephrology, vol. 23, pp. 106 - 111, http://dx.doi.org/10.1159/000068041

Johnson DW; Agard J; Collins J; Disney A; Harris DC; Ibels L; Irish AB; Saltissi D; Suranyi MG, 2003, 'Recommendations for the use of Icodextrin in peritoneal dialysis patients', Nephrology, vol. 8, pp. 1 - 7

Jefferys A; Suranyi M; Pokorny CS, 2002, 'The detection and investigation of pyuria', Medicine Today, vol. 3, pp. 63 - 66

Piira T; Chow J; Suranyi MG, 2002, 'The role of cognitive factors in the adjustment of home dialysis carers', Psychology and Health, vol. 17, pp. 313 - 322, http://dx.doi.org/10.1080/08870440290029566

Chow JSF; Suranyi MG, 2002, 'Anaemia in chronic renal failure', Current Therapeutics, vol. 43, pp. 7 - 11

Suranyi MG; Bannister KW, 2002, 'Practical experience with the Renal Anaemia Management Database', Nephrology, vol. 7, pp. S7 - S11

Lawrence CH; Chow J; Suranyi MG, 2002, 'Factors affecting haemodialysis-access survival in a single centre retrospective cohort study', Nephrology, vol. 7, pp. 72 - 76

Chow J; Munro C; Wong M; Gonzalez N; Ku M; Neville S; Munro R; Hall B; Cleland B; Howlin K, 2000, 'Homechoice automated peritoneal dialysis machines: The impact of reuse of tubing and cassettes', Peritoneal Dialysis International, vol. 20, pp. 336 - 338

Murphy B; Harris DJ; Disney A; Ibels L; Saltissi D; Rigby RJ; Suranyi MG; Collins J, 1999, 'Treatment of peritoneal dialysis related peritonitis- an Australian and New Zealand perspective', Australian and New Zealand Journal of Medicine, vol. 29, pp. 552 - 555

Suranyi MG; Hogan PG; Falkk MC; Axelsen RA; Rigby R; Hawley C; Petrie J, 1998, 'Advanced donor origin melanoma in a renal transplant recipient: Immunotherapy, cure, and retransplantation', Transplantation, vol. 66, pp. 655 - 661, http://dx.doi.org/10.1097/00007890-199809150-00020

Suranyi MG; Hogan PG; Falk MC; Axelsen RA; Rigby RJ; Hawley C; Petrie JB, 1998, 'Advanced donor origin melanoma in a renal transplant recipient: Immunotherapy, Cure and Retransplantation', Transplantation, vol. 66, pp. 655 - 661

Petrie JJB; Rigby RJ; Hawley CM; Suranyi MG; Whitby M; Wall D; Hardie IR, 1995, 'Effect of OKT3 in steroid-resistant renal transplant rejection', Transplantation, vol. 59, pp. 347 - 352

Suranyi MG; Guasch A; Hall BM; Myers BD, 1993, 'Elevated Levels of Tumor Necrosis Factor-α in the Nephrotic Syndrome in Humans', American Journal of Kidney Diseases, vol. 21, pp. 251 - 259, http://dx.doi.org/10.1016/S0272-6386(12)80742-6

Guasch A; Suranyi M; Newton L; Hall BM; Myers BD, 1992, 'Short-Term Responsiveness of Membranous Glomerulopathy to Cyclosporine', American Journal of Kidney Diseases, vol. 20, pp. 472 - 481, http://dx.doi.org/10.1016/S0272-6386(12)70259-7

Cox S; Lai J; Suranyi MG; Walker NA, 1992, 'Sclerosing peritonitis with gross peritoneal calcification: A case report', American Journal of Kidney Diseases, vol. 20, pp. 637 - 642

Suranyi MG; Bishop GA; Clayberger C; Krensky AM; Leenaerts P; Aversa G; Hall BM, 1991, 'Lymphocyte adhesion molecules in T cell-mediated lysis of human kidney cells', Kidney International, vol. 39, pp. 312 - 319, http://dx.doi.org/10.1038/ki.1991.39

SURANYI MG; QUIZA C; GAUSCH A; NEWTON L; MYERS BD; HALL BM, 1990, 'CYTOKINE LEVELS IN PATIENTS WITH THE NEPHROTIC SYNDROME', KIDNEY INTERNATIONAL, vol. 37, pp. 445 - 445, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1990CG53701064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

SURANYI MG; QUIZA C; GUASCH A; NEWTON L; MYERS BD; HALL BM, 1990, 'THE NEPHROTIC SYNDROME - ROLE OF CYTOKINES', KIDNEY INTERNATIONAL, vol. 38, pp. 557 - 557, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1990DV11100087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Suranyi MG; Bishop GA; Clayberger C; Krensky AM; Leenaerts P; Hall BM, 1990, 'The importance of the ICAM-1/LFA-1-dependent pathway in in vitro cytotoxicity against cultured human kidney cells', Transplantation Proceedings, vol. 22, pp. 2101 - 2102

Suranyi MG; Hall BM, 1990, 'Current status of renal transplantation', Western Journal of Medicine, vol. 152, pp. 687 - 696

Bishop A; Suranyi MG; Waugh J; Hall BM, 1989, 'Expression of adhesion molecules by human renal tubular cells in culture and binding of activated lymphocytes.', Transplant Proc, vol. 21, pp. 314 - 315, https://www.ncbi.nlm.nih.gov/pubmed/2705226

BISHOP A; SURANYI MG; WAUGH J; HALL BM, 1989, 'EXPRESSION OF ADHESION MOLECULES BY HUMAN RENAL TUBULAR CELLS IN CULTURE AND BINDING OF ACTIVATED LYMPHOCYTES', TRANSPLANTATION PROCEEDINGS, vol. 21, pp. 314 - 315, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1989U152300121&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bishop A; Suranyi MG; Waugh J; Hall BM, 1989, 'Expression of adhesion molecules by human renal tubular cells in culture and binding of activated lymphocytes', Transplantation Proceedings, vol. 21, pp. 314 - 315

Bishop GA; Suranyi MG; Waugh J; Hall BM, 1989, 'Expression of adhesion molecules by human renal tubular cells in culture and binding of activated lymphocytes', Transplantation Proceedings, vol. 21, pp. 314 - 315

SURANYI MG; HALL BM; DUGGIN GG; JOHNSON J; HORVATH JS; TILLER DJ, 1988, 'T-CELL IMMUNIZATION AFTER GRAFT LOSS FROM REJECTION', KIDNEY INTERNATIONAL, vol. 33, pp. 135 - 135, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988L610500049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

SURANYI MG; HALL BM; DUGGIN GG; JOHNSON J; HORVATH JS; TILLER DJ, 1988, 'ASSESSMENT OF T-CELL CROSSMATCH PRETRANSPLANT', KIDNEY INTERNATIONAL, vol. 33, pp. 138 - 138, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988L610500066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Aversa GG; Suranyi MG; Waugh JA; Bishop AG; Hall BM, 1988, 'Detection of a late lymphocyte activation marker by A1, a new monoclonal antibody', Transplantation Proceedings, vol. 20, pp. 49 - 52

Lissing JR; Tuch BE; Suranyi MG, 1988, 'The use of gliotoxin in human fetal pancreas transplantation', Transplantation Proceedings, vol. 20, pp. 76 - 78

Tuch BE; Lissing JR; Suranyi MG, 1988, 'Immunomodulation of human fetal cells by the fungal metabolite gliotoxin', Immunology and Cell Biology, vol. 66, pp. 307 - 312, http://dx.doi.org/10.1038/icb.1988.40

Aversa G; Suranyi MG; Waugh J; Bishop GA; Hall BM, 1988, 'Detection of a late lymphocyte activation marker by RPA A1, a new monoclonal antibody', Transplantation Proceedings, vol. 20, pp. 44 - 46

Aversa GG; Bishop GA; Suranyi MG; Hall BM, 1987, 'RPA-2.10: An anti-CD2 monoclonal antibody that inhibits alloimmune responses and monitors T cell activation', Transplantation Proceedings, vol. 19, pp. 277 - 278

Suranyi MG; Bishop GA; Waugh J; Hall BM, 1987, 'Target susceptibility in cell-mediated lympholysis assays correlates with major histocompatibility complex surface antigen expression', Transplantation Proceedings, vol. 19, pp. 2869 - 2872

Suranyi MG; Waugh J; Bishop GA; Hall BM, 1987, 'Cell-mediated lympholysis: Target susceptibility to lysis correlates with surface major histocompatibility complex expression', Transplantation Proceedings, vol. 19, pp. 417 - 420

Suranyi MG; Hall BM; Duggin GG; Horvath JS; Johnson JR; Sheil AG; Tiller DJ, 1987, 'T cell presensitization in renal transplantation', Transplantation Proceedings, vol. 19, pp. 896 - 897

Suranyi MG; Hall BM; Duggin GG; Horvath JS; Johnson JR; Sheil AG; Tiller DJ, 1987, 'Detection of T cell sensitization in renal transplant patients with mixed lymphocyte culture-cell-mediated lympholysis', Transplantation Proceedings, vol. 19, pp. 2873 - 2875

BISHOP GA; SURANYI MG; WAUGH J; HALL BM, 1986, 'INVOLVEMENT OF GAMMA-INTERFERON INDUCED HLA-ANTIGEN EXPRESSION IN MECHANISMS OF T-CELL CYTOTOXICITY', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, vol. 16, pp. 170 - 170, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1986A500500204&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bishop GA; Suranyi MJ; Hall BM; Duggin GG; Tiller DJ; Horvath JS, 1986, 'Induction of HLA-DR antigens on cultured human kidney cells', Transplantation Proceedings, vol. 18, pp. 290 - 292

Bishop GA; Hall BM; Suranyi MG; Tiller DJ; Horvath JS; Duggin GG, 1986, 'Expression of HLA antigens on renal tubular cells in culture: I. Evidence that mixed lymphocyte culture supernatants and gamma interferon increase both class I and class II HLA antigens', Transplantation, vol. 42, pp. 671 - 679

Bishop GA; Hall BM; Suranyi MG; Tiller D; Horvath J; Duggin G, 1986, 'Expression of HLA antigens on renal tubular cells in culture. I. MLC supernatant and gamma interferon increase both class I and class II HLA antigens', Transplantation, vol. 42, pp. 671

Eisinger DR; Suranyi MG; Bracs P; Farnsworth A; Shell AGR, 1985, 'EFFECTS OF VERAPAMIL IN THE PREVENTION OF WARM ISCHAEMIA INDUCED ACUTE RENAL FAILURE IN DOGS', Australian and New Zealand Journal of Surgery, vol. 55, pp. 391 - 396, http://dx.doi.org/10.1111/j.1445-2197.1985.tb00907.x

Chau K; Spicer T; Cleland B; Suranyi M; Makris A, 2011, 'A CASE OF RECURRENT SEVERE PREECLAMPSIA ASSOCIATED WITH ESSENTIAL CRYOFIBRINOGENAEMIA', in NEPHROLOGY, WILEY-BLACKWELL, pp. 56 - 56, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294977600123&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hassan HC; Howlin K; Jefferys A; Spicer ST; Aravindan AN; Suryanarayanan G; Hall BM; Cleland BD; Wong JK; Suranyi MG, 2014, 'High-sensitivity troponin as a predictor of cardiac events and mortality in the stable dialysis population', in Clinical Chemistry, Vol. 60, pp. 389 - 398, http://dx.doi.org/10.1373/clinchem.2013.207142

Wong J; Suryanarayanan G; Spicer ST; Jefferys A; Howlin K; Cleland B; Hall BM; Makris A; Suranyi MG; Aravindan A, 2012, 'Y-TEC (TM) peritoneoscopic peritoneal dialysis catheter insertion at Liverpool Hospital - a 5 year experience', in Nephrology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. 17 65-65; 2 SI AUG 2012, presented at Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, 01 January 2012

Wong JKW; Aravindan AN; Suryanarayanan G; Cleland B; Jefferys A; Makris A; Howlin K; Hall B; Suranyi M; Spicer ST, 2011, 'A NEPHROLOGIST RUN PRE-OPERATIVE PERITONEAL DIALYSIS ACCESS CLINIC: A SINGLE CENTRE EXPERIENCE', in NEPHROLOGY, WILEY-BLACKWELL, Vol. 16, pp. 45 - 45, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294977600081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cleland B; Suranyi MG; Rayment G; Hall BM; Howlin K; Makris A; Spicer ST; Wong J; Chow J, 2011, 'Time and motion study - The benefit of erythropoetin stimulating agents (ESA) synchronizating in a single dialysis unit', in Nephrology, Blackwell Publishing Asia, Philadelphia, pp. 74 - 74, presented at Asian Pacific Society of Nephrology, Philadelphia, 01 November 2011

Suranyi MG; Aravindan A; Cleland B; Hall BM; Jefferys A; Howlin K; Makris A; Spicer ST; Survanaravanan G; Wong J, 2011, 'Vancomycin resistant enterococci in haemodialysis unit, isolation and screening', in Nephrology, Blackwell Publishing Asia, Philadelphia, pp. 73 - 74, presented at Asian Pacific Society of Nephrology, Philadelphia, 01 November 2011

Aravindan A; Suryanarayanan G; Howlin K; Jeffreys A; Spicer T; Cleland B; Wong J; Hall B; Yong J; Suranyi MG, 2009, 'AN UNUSUAL RENAL MANIFESTATION OF HBV INFECTION', in NEPHROLOGY, WILEY-BLACKWELL PUBLISHING, INC, Vol. 14, pp. A48 - A48, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270272500177&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jefferys A; Chow J; Hall BM; Howlin K; Cleland B; Suranyi MG, 2001, 'Use of acute vascular access catheters (AVACs): A survey of the implications', in 37th Annual Scientific Meeting of the ANZSN, 37th Annual Scientific Meeting of the ANZSN, Darwin, Northern Territory, pp. 40 - 40, presented at 37th Annual Scientific Meeting of the ANZSN, Darwin, Northern Territory, 05 - 07 September 2001